Soleno Therapeutics, Inc. (SLNO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Soleno Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 117.86x | -10.27x | -17.03x | -3.45x | -5.29x | -24.53x |
| P/B Ratio | 5.47x | 7.37x | 4.21x | 8.03x | 9.19x | 13.27x |
| P/S Ratio | 12.93x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 98.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 7.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 11.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 14.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.80x | 15.68x | 14.89x | 2.14x | 2.80x | 5.83x |
| Quick Ratio | 5.55x | 15.68x | 14.89x | 2.14x | 2.80x | 5.83x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.22x | 0.00x | 0.01x | 0.03x | 0.00x |
YoY = year-over-year change. Source: FMP..